Only for EpCam, which has been recently suggested to be involved in the development of the aggressive phenotype of ATC [31] and has evoked significant interest as a target in cancer therapy [32] we analyzed protein expression changes in proliferating, starved (T0) and EGF-induced (T24) FRO, TPC1 and BC-PAP cells. Here, EPCAM is linked to breast cancer.